Bariatric surgery is associated with improvement in kidney outcomes

Kidney International

Volumn 90, Issue 1, 2016, Pages 164-171

  Chang, Alex R ^a   Chen, Yuan ^b   Still, Christopher ^a   Wood, G Craig ^a   Kirchner, H Lester ^a   Lewis, Meredith ^a   Kramer, Holly ^c   Hartle, James E ^a   Carey, David ^a   Appel, Lawrence J ^b,d   Grams, Morgan E ^b,d  

^a GEISINGER HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bariatric surgery; gastric bypass; GFR; glomerular filtration rate; kidney function; morbid obesity; Roux en Y surgery; weight loss

Indexed keywords

CREATININE;

ADULT; ADVERSE OUTCOME; ARTICLE; BARIATRIC SURGERY; CLINICAL OUTCOME; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL; RISK REDUCTION; WEIGHT REDUCTION; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; PATHOPHYSIOLOGY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; BARIATRIC SURGERY; COHORT STUDIES; CREATININE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84988443618     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.02.039     Document Type: Article

References (41)

1. 1 Flegal, K.M., Carroll, M.D., Kit, B.K., Ogden, C.L., Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307 (2012), 491–497.
2. 2 Prospective Studies Collaboration, Whitlock, G., Lewington, S., Sherliker, P., et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373 (2009), 1083–1096.
3. 3 Hsu, C.Y., McCulloch, C.E., Iribarren, C., et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006), 21–28.
4. 4 Vivante, A., Golan, E., Tzur, D., et al. Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med 172 (2012), 1644–1650.
5. 5 Sjostrom, L., Peltonen, M., Jacobson, P., et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311 (2014), 2297–2304.
6. 6 Schauer, P.R., Bhatt, D.L., Kirwan, J.P., et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes. N Engl J Med 370 (2014), 2002–2013.
7. 7 Maggard-Gibbons, M., Maglione, M., Livhits, M., et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA 309 (2013), 2250–2261.
8. 8 Navaneethan, S.D., Yehnert, H., Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis 5 (2009), 662–665.
9. 9 Bolignano, D., Zoccali, C., Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant 28:Suppl 4 (2013), iv82–iv98.
10. 10 Chagnac, A., Weinstein, T., Herman, M., et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14 (2003), 1480–1486.
11. 11 Friedman, A.N., Moe, S., Fadel, W.F., et al. Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol 39 (2014), 8–15.
12. 12 Navaneethan, S.D., Malin, S.K., Arrigain, S., et al. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis 65 (2015), 345–347.
13. 13 Brenner, B.M., Lawler, E.V., Mackenzie, H.S., The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49 (1996), 1774–1777.
14. 14 MacLaughlin, H.L., Hall, W.L., Patel, A.G., et al. Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study. Am J Kidney Dis 64 (2014), 660–663.
15. 15 Wolf, G., Ziyadeh, F.N., Leptin and renal fibrosis. Contrib Nephrol 151 (2006), 175–183.
16. 16 Sharma, K., Ramachandrarao, S., Qiu, G., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118 (2008), 1645–1656.
17. 17 Gupta, J., Mitra, N., Kanetsky, P.A., et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 7 (2012), 1938–1946.
18. 18 Fenske, W.K., Dubb, S., Bueter, M., et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis 9 (2013), 559–568.
19. 19 Navaneethan, S.D., Jolly, S.E., Schold, J.D., et al. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol 6 (2011), 40–49.
20. 20 Wiggins, J.E., Goyal, M., Sanden, S.K., et al. Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 16 (2005), 2953–2966.
21. 21 Sharma, K., The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int 76 (2009), 145–148.
22. 22 Kopp, H.P., Krzyzanowska, K., Mohlig, M., et al. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 29 (2005), 766–771.
23. 23 Agrawal, V., Khan, I., Rai, B., et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol 70 (2008), 194–202.
24. 24 Illan-Gomez, F., Gonzalvez-Ortega, M., Orea-Soler, I., et al. Obesity and inflammation: Change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 22 (2012), 950–955.
25. 25 Friedman, A.N., Quinney, S.K., Inman, M., et al. Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study. Am J Kidney Dis 63 (2014), 598–603.
26. 26 Hao, C.M., Haase, V.H., Sirtuins and their relevance to the kidney. J Am Soc Nephrol 21 (2010), 1620–1627.
27. 27 Lieske, J.C., Mehta, R.A., Milliner, D.S., Rule, A.D., Bergstralh, E.J., Sarr, M.G., Kidney stones are common after bariatric surgery. Kidney Int 87 (2015), 839–845.
28. 28 Kumar, R., Lieske, J.C., Collazo-Clavell, M.L., et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery 149 (2011), 654–661.
29. 29 Park, A.M., Storm, D.W., Fulmer, B.R., et al. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery. J Urol 182 (2009), 2334–2339.
30. 30 Nasr, S.H., D'Agati, V.D., Said, S.M., et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 3 (2008), 1676–1683.
31. 31 Dimick, J.B., Nicholas, L.H., Ryan, A.M., et al. Bariatric surgery complications before vs after implementation of a national policy restricting coverage to centers of excellence. JAMA 309 (2013), 792–799.
32. 32 Chang, A., Greene, T.H., Wang, X., et al. The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant 39 (2015), 1870–1877.
33. 33 Perrone, R.D., Madias, N.E., Levey, A.S., Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38 (1992), 1933–1953.
34. 34 Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
35. 35 Pourhassan, M., Bosy-Westphal, A., Schautz, B., et al. Impact of body composition during weight change on resting energy expenditure and homeostasis model assessment index in overweight nonsmoking adults. Am J Clin Nutr 99 (2014), 779–791.
36. 36 Hinnouho, G.M., Czernichow, S., Dugravot, A., et al. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?. Diabetes Care 36 (2013), 2294–2300.
37. 37 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106 (2002), 3143–3421.
38. 38 Rubin, D.B., Thomas, N., Matching using estimated propensity scores: relating theory to practice. Biometrics 52 (1996), 249–264.
39. 39 Perrin, N., Berg, U.B., Estimated glomerular filtration rates cannot replace measured GFR in type 1 diabetes patients with hyperfiltration. Acta Paediatr 104 (2015), 730–737.
40. 40 Coresh, J., Turin, T.C., Matsushita, K., et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311 (2014), 2518–2531.
41. 41 Levey, A.S., Inker, L.A., Matsushita, K., et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 64 (2014), 821–835.